Connexins: The basis of functional coupling of myocytes

Journal of Clinical and Basic Cardiology

Volumn 8, Issue 1-4, 2005, Pages 19-22

  Alex, J ^a,b   Cale, A R J ^a   Griffin, S C ^a   Cowen, M E ^a   Guvendik, L ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

^b The Cottage   (United Kingdom)

Author keywords

Connexin; Gap junction; Myocardial coupling

Indexed keywords

CALCIUM; GAP JUNCTION PROTEIN;

CALCIUM CONDUCTANCE; CALCIUM METABOLISM; CARBOXY TERMINAL SEQUENCE; CELL COMMUNICATION; CELL MEMBRANE PERMEABILITY; CONGESTIVE CARDIOMYOPATHY; GAP JUNCTION; HEART ATRIUM MUSCLE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE HYPERTROPHY; HUMAN; INTERCALATION COMPLEX; MYOCARDIAL HIBERNATION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PURKINJE CELL; REVIEW;

EID: 31744435477     PISSN: 15612775     EISSN: 16809386     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Saffitz JE. Gap junctions: functional effects of molecular structure and tissue distribution. In: Sideman, Bayer (eds). Analytical and quantitative cardiology. Plenum Press, New York, 1997; 291-301.
2. Page E. Cardiac gap junctions. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE (eds). The heart and cardiovascular system. Raven Press, New York, 1992; 1003-47.
3. Severs NJ, Dupont E, Kaprielian RR, Yeh HI, Rothery S. Gap junctions and connexins in the cardiovascular system. In: Yacoob MH, Carpentier A, Pepper J et al. (eds). Annual of cardiac surgery. Current Science, London, 1996; 9: 31-44.
4. Severs NJ. The cardiac muscle cell. Bioessays 2000; 22: 188-99.
5. Goodenough DA, Goliger JA, Paul DL. Connexins, connexons, and intercellular communication. Ann Rev Biochem 1996; 65: 475-502.
6. Severs NJ. Cardiac gap junction and intercalated disk. Int J Cardiol 1990; 26: 137-73.
7. Kanter HL, Saffitz JE, Beyer EC. Cardiac myocytes express multiple gap junction proteins. Circ Res 1992; 70: 438-44.
8. Beyer EC, Goodenough DA, Paul DL. Connexin family of gap junction proteins. J Membr Biol 1990; 116: 187-94.
9. Stergiopoulos K, Alvarado JL, Mastroianni M, Ek-Vitorin JF, Taffet SM, Delmar M. Hetero-domain interactions as a mechanism for the regulation of connexin channels. Circ Res 1999; 84: 1144-55.
10. Moreno AP, Saez JC, Fishman GI, Spray DC. Human connexin 43 gap junction channels. Regulation of unitary conductances by phosphorylation. Circ Res 1994; 74: 1050-7.
11. Gu H, Ek-Vitorin JF, Taffet SM, Delmar M. Coexpression of connexins 40 and 43 enhances the pH sensitivity of gap junctions. A model for synergistic interactions among connexins. Circ Res 2000; 86: 98-103.
12. Veenstra RD, Wang HZ, Westphale EM, Beyer EC. Multiple connexins confer distinct regulatory and conductance properties of gap junctions in developing heart. Circ Res 1992; 71: 1277-83.
13. Saffitz JE, Laing JG, Yamada KA. Connexin expression and turnover. Implications for cardiac excitability. Circ Res 2000; 86: 723-8.
14. Gourdie RG, Severs NH, Green CR, Rothery S, Germroth P, Thompson RP. The spatial distribution and relative abundance of gap junctional connexin 40 and connexin 43 correlate to functional properties of components of the cardiac atrioventricular conduction system. J Cell Sci 1993; 105: 985-91.
15. Davis LM, Kanter HL, Beyer EC, Saffitz JE. Distinct gap junction protein phenotypes in cardiac tissues with disparate conduction properties. J Am Coll Cardiol 1994; 24; 1124-32.
16. Davis LM, Rodefield ME, Green K, Bayer EC, Saffitz JE. Gap junction protein phenotypes of human heart and conduction system. J Cardiovasc Electrophysiol 1995; 6: 813-22.
17. Valiunas V, Weingart R, Brink PR. Formation of heterotypic gap junction channels by Connexins 40 and 43. Circ Res 2000; 86: 42-9.
18. Gros D, Jarry-Guichard T, Ten Velde I, De Maziere A, Van Kempen MJ, Davoust J, Braind JP, Moorman AF, Jongsma HJ. Restricted distribution of connexin 40, a gap junctional protein, in mammalian heart. Circ Res 1994; 74: 839-51.
19. Lo CW. Role of gap junctions in cardiac conduction and development. Circ Res 2000; 87: 346-50.
20. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Jeneja SC, Kidder GM, Rossant J. Cardiac malformation in neonatal mice lacking connexin 43. Science 1995; 267: 1831-4.
21. Thomas SA, Schuessler RB, Berul CI, Beardslee MA, Beyer EC, Mendelson ME, Saffitz JE. Disparate effects of deficient expression of connexin 43 on atrial and ventricular conduction. Evidence for chamber-specific molecular determinants of conduction. Circulation 1998; 97: 686-91.
22. Guerrero PA, Schuessler RB, Davis LM, Beyer EC, Johnson CM, Yamada KA, Saffitz JE. Slow ventricular conduction in mice heterozygous for a connexin 43 null mutation. J Clin Invest 1997; 99: 1991-8.
23. Severs NJ. Gap junctions and coronary heart disease. In: DeMello WC, Jane MJ (eds). Heart cell communication in health and disease. Kluwer, Boston, 1998; 175-94.
24. Severs NJ. Cardiovascular disease. In: Cardew G (ed). Gap junction mediated intercellular signalling in health and disease. John Wiley & Sons Ltd., New York, 1999; 188-206.
25. Peters NS, Severs NJ, Coromilas J, Wit AL. Disturbed connexin 43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 1997; 95: 988-96.
26. Luke RA, Saffitz JE. Remodelling of ventricular conduction pathways in healed canine infarct border zones. J Clin Invest 1991; 87: 1594-602.
27. Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh HI, Ko YS, Matsushita T, Kaba R, Halliday D. Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech 2001; 52: 301-22.
28. Peters NS, Green CR, Pool-Wilson PA, Severs NJ. Reduced content of connexin 43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 1993; 88: 864-75.
29. Saffitz JE, Yamada KA. Do alterations in intercellular coupling play a role in cardiac contractile dysfunction? Circulation 1998; 97: 630-2
30. Saffitz JE, Beyer EC, Darrow BJ, Guerrero PA, Beardslee MA, Dodge SM. Gap junction structure, conduction, and arrhythmogenesis: direction of future research. In: Spooner PM, Joyner RW, Jalife J (eds). Discontinuous conduction in heart. Futura Publishing Company, New York, 1997; 89-105.
31. Dupont E, Ko YS, Rothery S, Coppen SR, Baghai M, Haw M, Severs NJ. The gap-junctional protein connexin 40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation 2001; 103: 842-9.
32. Van der Velden HM, Ausma J, Rook MB, Hellemons AJ, Van Veena TA, Allessie MA, Jongsma HJ. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 2000; 46: 476-86.
33. Polontchouk L, Haefliger JA, Ebelt B, Schaefer T, Stuhlmann D, Mehlhorn U, Kuhn-Regnier F, Vivie ERD, Dhein S. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 2001; 38: 883-91.
34. Thijssena VLJL, Ausmab J, Borger M. Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovasc Res 2001; 52, 14-24.
35. Bosch RF, Grammer JB, Kühlkamp V, Seipel L. Electrical remodelling in atrial fibrillation - cellular and molecular mechanisms. Z Kardiol 2000; 89: 795-802.
36. Ausmab J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997; 96: 3157-63.
37. Thomas SA, Schuessler RB, Saffitz JE. Connexins, conduction, and atrial fibrillation. J Cardiovasc Electrophysiol 1998; 9: 608-11.
38. Saffitz JE, Kanter HL, Green KG, Tolley TK, Beyer EC. Tissue specific determinants of anisotropic conduction velocity in canine atrial and ventricular myocardium. Circ Res 1994; 74: 1065-70.
39. Tieleman RG, Crijns HJGM. The 'Second Factor' of tachycardia-induced atrial remodelling. Cardiovasc Res 2000; 46: 364-6.